TY - JOUR
T1 - NF-κB1 (p50) Homodimers Contribute to Transcription of the bcl-2 Oncogene
AU - Kurland, John F.
AU - Kodym, Reinhard
AU - Story, Michael D.
AU - Spurgers, Kevin B.
AU - McDonnell, Timothy J.
AU - Meyn, Raymond E.
PY - 2001/11/30
Y1 - 2001/11/30
N2 - The bcl-2 proto-oncogene is frequently expressed in human cancer. Although bcl-2 was first cloned as the t(14;18) translocation breakpoint from human follicular B-cell lymphoma, it has become apparent that many cell types express bcl-2 because of transcriptional regulation. As such, several transcription factors have been demonstrated to activate expression of bcl-2, including NF-κB. We investigated the role of NFκB1 (p50) homodimers in the expression of Bcl-2 in two murine B-cell lymphoma cell lines: LY-as, an apoptosis-proficient line with low Bcl-2 protein expression and no nuclear NF-κB activity, and LY-ar, a nonapoptotic line with constitutive p50 homodimer activity and 30 times more Bcl-2 protein expression than LY-as. We found that nuclear p50 homodimer activity correlated with Bcl-2 expression in these cell types and identified several sites within the bcl-2 5′-flanking region that p50 was capable of binding. In vitro transcription revealed that recombinant p50 enhanced the production of run-off transcripts from the bcl-2 P1 promoter. Additional in vitro transcription experiments suggested the sites by which p50 afforded this effect. We conclude that the p50 homodimer is capable of transcriptional activation of the bcl-2 gene and suggest that its nuclear activity contributes to the expression of bcl-2 in LY-ar cells.
AB - The bcl-2 proto-oncogene is frequently expressed in human cancer. Although bcl-2 was first cloned as the t(14;18) translocation breakpoint from human follicular B-cell lymphoma, it has become apparent that many cell types express bcl-2 because of transcriptional regulation. As such, several transcription factors have been demonstrated to activate expression of bcl-2, including NF-κB. We investigated the role of NFκB1 (p50) homodimers in the expression of Bcl-2 in two murine B-cell lymphoma cell lines: LY-as, an apoptosis-proficient line with low Bcl-2 protein expression and no nuclear NF-κB activity, and LY-ar, a nonapoptotic line with constitutive p50 homodimer activity and 30 times more Bcl-2 protein expression than LY-as. We found that nuclear p50 homodimer activity correlated with Bcl-2 expression in these cell types and identified several sites within the bcl-2 5′-flanking region that p50 was capable of binding. In vitro transcription revealed that recombinant p50 enhanced the production of run-off transcripts from the bcl-2 P1 promoter. Additional in vitro transcription experiments suggested the sites by which p50 afforded this effect. We conclude that the p50 homodimer is capable of transcriptional activation of the bcl-2 gene and suggest that its nuclear activity contributes to the expression of bcl-2 in LY-ar cells.
UR - http://www.scopus.com/inward/record.url?scp=0035976997&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035976997&partnerID=8YFLogxK
U2 - 10.1074/jbc.M108294200
DO - 10.1074/jbc.M108294200
M3 - Article
C2 - 11567031
AN - SCOPUS:0035976997
SN - 0021-9258
VL - 276
SP - 45380
EP - 45386
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 48
ER -